{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:55:04Z","timestamp":1788432904066,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ypmed.2023.107777","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T11:32:09Z","timestamp":1699875129000},"page":"107777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The United States opioid crisis: Big pharma alone is not to blame.\u201d"],"prefix":"10.1016","volume":"177","author":[{"given":"Peggy","family":"Compton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2023.107777_bb0005","series-title":"Acute Pain Management: Operative or Medical Procedures and Trauma, Clinical Practice Guideline","author":"Acute Pain Management Guideline Panel","year":"1992"},{"issue":"1","key":"10.1016\/j.ypmed.2023.107777_bb0015","first-page":"6","article-title":"The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society","volume":"13","author":"American Academy of Pain Medicine and American Pain Society","year":"1997","journal-title":"Clin. J. Pain"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0020","first-page":"28","article-title":"Definitions related to the use of opioids for the treatment of pain","volume":"100","author":"American Academy of Pain Medicine, the American Pain Society and the American Society of Addition Medicine","year":"2001","journal-title":"WMJ"},{"issue":"23","key":"10.1016\/j.ypmed.2023.107777_bb0025","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.1995.03530230060032","article-title":"Quality improvement guidelines for the treatment of acute pain and cancer pain","volume":"274","author":"American Pain Society Quality of Care Committee","year":"1995","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.ypmed.2023.107777_bb0030","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ypmed.2023.107777_bb0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/AJP.0b013e31816b2f26","article-title":"Efficacy of opioids for chronic pain: a review of the evidence","volume":"24","author":"Ballantyne","year":"2008","journal-title":"Clin. J. Pain"},{"issue":"6","key":"10.1016\/j.ypmed.2023.107777_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2023.107777_bb0045","doi-asserted-by":"crossref","DOI":"10.2202\/1548-923X.1645","article-title":"Survey on addictions: toward curricular change for family nurse practitioners","volume":"6","author":"Campbell-Heider","year":"2009","journal-title":"Int. J. Nurs. Educ. Scholarsh."},{"key":"10.1016\/j.ypmed.2023.107777_bb0050","series-title":"CDC advises against misapplication of the guideline for prescribing opioids for chronic pain","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.ypmed.2023.107777_bb0055","unstructured":"Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. (2021, November 10). U.S. opioid dispensing rate maps. https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html."},{"key":"10.1016\/j.ypmed.2023.107777_bb0060","series-title":"Provisional data shows U.S. drug overdose deaths top 100,000 in 2022","author":"Centers for Disease Control and Prevention, National Center for Health Statistics","year":"2023"},{"issue":"7","key":"10.1016\/j.ypmed.2023.107777_bb0065","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jpain.2019.01.011","article-title":"Development of the revised opioid risk tool to predict opioid use disorder in patients with chronic nonmalignant pain","volume":"20","author":"Cheatle","year":"2019","journal-title":"J. Pain"},{"issue":"7","key":"10.1016\/j.ypmed.2023.107777_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-147-7-200710020-00008","article-title":"Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society\/American College of Physicians clinical practice guideline","volume":"147","author":"Chou","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J. Pain"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0885-3924(93)90158-R","article-title":"Opioids, chronic pain, and the law","volume":"8","author":"Clark","year":"1993","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ypmed.2023.107777_bb0085","series-title":"Doctor liable for not giving enough pain medicine","author":"CNN","year":"2001"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232538","article-title":"Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain","volume":"15","author":"Coffin","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2023.107777_bib451","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jpainsymman.2007.11.006","article-title":"Introduction of Self-report Version of the Prescription Drug Use Questionnaire and Relationship to Medication Agreement Non-compliance","volume":"(4):","author":"Compton","year":"2008","journal-title":"J. Pain and Symptom Manage. 36"},{"key":"10.1016\/j.ypmed.2023.107777_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.genhosppsych.2017.04.011","article-title":"Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users","volume":"47","author":"Demidenko","year":"2017","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.ypmed.2023.107777_bb0100","series-title":"Pain: The fifth vital sign toolkit","author":"Department of Veterans Affairs","year":"2000"},{"issue":"10","key":"10.1016\/j.ypmed.2023.107777_bb0105","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1185\/030079905X65321","article-title":"Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain","volume":"21","author":"Devulder","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"issue":"12","key":"10.1016\/j.ypmed.2023.107777_bb0110","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jpain.2013.07.006","article-title":"A blueprint of pain curriculum across prelicensure health sciences programs: one NIH Pain Consortium Center of Excellence in Pain Education (CoEPE) experience","volume":"14","author":"Doorenbos","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.ypmed.2023.107777_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016","volume":"65(No. RR-1)","author":"Dowell","year":"2016","journal-title":"MMWR recommendations and reports"},{"key":"10.1016\/j.ypmed.2023.107777_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","volume":"71(No. RR-3)","author":"Dowell","year":"2022","journal-title":"MMWR Recomm. Rep."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0125","first-page":"147","article-title":"A joint statement from 21 health organizations and the Drug Enforcement Administration. Promoting pain relief and preventing abuse of pain medications: a critical balancing act","volume":"24","author":"Drug Enforcement Administration","year":"2001","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ypmed.2023.107777_bb0130","series-title":"21 CFR Part 1306, Dispensing controlled substances for the treatment of pain","author":"Drug Enforcement Administration","year":"2006"},{"key":"10.1016\/j.ypmed.2023.107777_bb0135","first-page":"CD006146","article-title":"Opioids for neuropathic pain","volume":"3","author":"Eisenberg","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ypmed.2023.107777_bb0140","series-title":"Joint Meeting of Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee","author":"FDA Briefing Document","year":"2020"},{"key":"10.1016\/j.ypmed.2023.107777_bb0145","series-title":"Model guidelines for the use of controlled substances for the treatment of pain","author":"Federation of State Medical Boards of the United States","year":"1998"},{"key":"10.1016\/j.ypmed.2023.107777_bb0155","series-title":"Guidelines for the chronic use of opioid analgesics","author":"Federation of State Medical Boards of the United States","year":"2017"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3959(92)90145-2","article-title":"Efficacy of multidisciplinary pain treatment centers: a meta-analytic review","volume":"49","author":"Flor","year":"1992","journal-title":"Pain"},{"issue":"13","key":"10.1016\/j.ypmed.2023.107777_bb0170","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMe030014","article-title":"Opioids and chronic neuropathic pain","volume":"348","author":"Foley","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1191\/0269216303pm762ed","article-title":"Advancing palliative care in the United States","volume":"17","author":"Foley","year":"2003","journal-title":"Palliat. Med."},{"issue":"1 Suppl","key":"10.1016\/j.ypmed.2023.107777_bb0180","first-page":"S2","article-title":"Perspectives on the medical use of drugs of abuse","volume":"5","author":"Friedman","year":"1990","journal-title":"J. Pain Symptom Manag."},{"issue":"11","key":"10.1016\/j.ypmed.2023.107777_bb0185","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","article-title":"Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects","volume":"174","author":"Furlan","year":"2006","journal-title":"CMAJ"},{"issue":"26","key":"10.1016\/j.ypmed.2023.107777_bb0190","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"7301","key":"10.1016\/j.ypmed.2023.107777_bb0195","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/bmj.322.7301.1511","article-title":"Multidisciplinary rehabilitation for chronic low back pain: systematic review","volume":"322","author":"Guzm\u00e1n","year":"2001","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.ypmed.2023.107777_bb0200","article-title":"Tighter prescribing regulations drive illicit opioid sales","volume":"361","author":"Hadland","year":"2018","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.ypmed.2023.107777_bb0205","article-title":"Drug overdose deaths in the United States, 1999\u20132016","volume":"no 294","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0885-3924(95)00203-0","article-title":"Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin","volume":"11","author":"Hill","year":"1996","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ypmed.2023.107777_bb0215","series-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","author":"Institute of Medicine","year":"2011"},{"key":"10.1016\/j.ypmed.2023.107777_bb0220","series-title":"Pain and Disability: Clinical, Behavioral, and Public Policy Perspectives","author":"Institute of Medicine (US) Committee on Pain, Disability, and Chronic Illness Behavior","year":"1987"},{"issue":"9","key":"10.1016\/j.ypmed.2023.107777_bb0225","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJM199403033300926","article-title":"New clinical-practice guidelines for the management of pain in patients with cancer","volume":"330","author":"Jacox","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2023.107777_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101198","article-title":"Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study","volume":"42","author":"Jayawardana","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ypmed.2023.107777_bb0235","series-title":"Multidisciplinary pain programs for chronic noncancer pain, Comparative effectiveness technical briefs, No. 8. Agency for Healthcare Research and Quality","author":"Jeffery","year":"2011"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0240","first-page":"1","article-title":"Intractable pain treatment Laws and Regulations","volume":"5","author":"Joranson","year":"1995","journal-title":"Am. Pain Soc. Bull."},{"issue":"Suppl A","key":"10.1016\/j.ypmed.2023.107777_bb0245","first-page":"3A","article-title":"Use of opioid analgesics for the treatment of chronic noncancer pain--a consensus statement and guidelines from the Canadian Pain Society","volume":"8","author":"Jovey","year":"2003","journal-title":"Pain Res. Manag."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1090-3801(02)00143-X","article-title":"Recommendations for using opioids in chronic non-cancer pain","volume":"7","author":"Kalso","year":"2003","journal-title":"Eur J Pain (London, England)"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107777_bb0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.ypmed.2023.107777_bb0260","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1176\/ajp.142.10.1156","article-title":"Chronic pain: lifetime psychiatric diagnoses and family history","volume":"142","author":"Katon","year":"1985","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0265","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1097\/j.pain.0000000000002573","article-title":"Prevalence of addiction in chronic pain: reanalysis of Vowles et al., 2015","volume":"163","author":"Keyes","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.ypmed.2023.107777_bb0270","series-title":"A nation in overdose peril: Pinpointing the most impacted communities and the local gaps in care","author":"Kneebone","year":"2017"},{"issue":"3","key":"10.1016\/j.ypmed.2023.107777_bb0275","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","article-title":"Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012","volume":"49","author":"Levy","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107777_bb0280","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(02)00020-9","article-title":"Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS)","volume":"97","author":"Maier","year":"2002","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","article-title":"Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction","volume":"146","author":"Martell","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2023.107777_bb0290","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0304-3959(81)90638-2","article-title":"Problems with the use of oxycodone compound in patients with chronic pain","volume":"11","author":"Maruta","year":"1981","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.ypmed.2023.107777_bb0295","doi-asserted-by":"crossref","first-page":"885","DOI":"10.7326\/0003-4819-113-11-885","article-title":"Improving outcomes of analgesic treatment: is education enough?","volume":"113","author":"Max","year":"1990","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.ypmed.2023.107777_bb0300","first-page":"CD006146","article-title":"Opioids for neuropathic pain","volume":"2013","author":"McNicol","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/scientificamerican0290-27","article-title":"The tragedy of needless pain","volume":"262","author":"Melzack","year":"1990","journal-title":"Sci. Am."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0310","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00001888-200105000-00007","article-title":"Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders","volume":"76","author":"Miller","year":"2001","journal-title":"Acad. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0315","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1186\/ar1782","article-title":"Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"1\u20132","key":"10.1016\/j.ypmed.2023.107777_bb0320","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1300\/J251v05n01_11","article-title":"American opiophobia: customary underutilization of opioid analgesics","volume":"5","author":"Morgan","year":"1985","journal-title":"Adv. Alcohol Subst. Abuse"},{"key":"10.1016\/j.ypmed.2023.107777_bb0325","author":"Muhuri"},{"issue":"8","key":"10.1016\/j.ypmed.2023.107777_bb0330","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.ypmed.2023.107777_bb0335","unstructured":"National Institutes of Health. (2015, November 18) News Releases: 10 percent of US adults have drug use disorder at some point in their lives. https:\/\/www.nih.gov\/news-events\/news-releases\/10-percent-us-adults-have-drug-use-disorder-some-point-their-lives#:\u223c:text=November%2018%2C%202015-,10%20percent%20of%20US%20adults%20have%20drug%20use%20disorder%20at,disorders%20and%20often%20goes%20untreated."},{"key":"10.1016\/j.ypmed.2023.107777_bb0345","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugpo.2018.03.016","article-title":"Offline constraints in online drug marketplaces: an exploratory analysis of a cryptomarket trade network","volume":"56","author":"Norbutas","year":"2018","journal-title":"Int. J. Drug Policy"},{"issue":"5","key":"10.1016\/j.ypmed.2023.107777_bb0350","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1360-0443.2010.03144.x","article-title":"Addiction and dependence in DSM-V","volume":"106","author":"O\u2019Brien","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.ypmed.2023.107777_bb0355","series-title":"Review of the drug enforcement administration\u2019s regulatory and enforcement efforts to control the diversion of opioids","author":"Office of the Inspector General, U.S. Department of Justice","year":"2019"},{"key":"10.1016\/j.ypmed.2023.107777_bb0360","series-title":"Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C.\u202f: 2002)","first-page":"1","article-title":"Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013","volume":"64(9)","author":"Paulozzi","year":"2015"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107777_bb0365","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jama.284.4.423b","article-title":"JCAHO pain management standards are unveiled. Joint commission on accreditation of healthcare organizations","volume":"284","author":"Phillips","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0370","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3959(86)90091-6","article-title":"Chronic use of opioid analgesics in non-malignant pain: report of 38 cases","volume":"25","author":"Portenoy","year":"1986","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.ypmed.2023.107777_bb0375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM198001103020221","article-title":"Addiction rare in patients treated with narcotics","volume":"302","author":"Porter","year":"1980","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ypmed.2023.107777_bb0380","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.160.6.853","article-title":"Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation","volume":"160","author":"Roth","year":"2000","journal-title":"Arch. Intern. Med."},{"issue":"13","key":"10.1016\/j.ypmed.2023.107777_bb0385","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2023.107777_bb0390","first-page":"13","article-title":"Report of the commission on the evaluation of pain","volume":"50","year":"1987","journal-title":"Soc. Secur. Bull."},{"key":"10.1016\/j.ypmed.2023.107777_bb0400","series-title":"Key substance use and mental health indicators in the United States: results from the 2020 national survey on drug use and health","author":"Substance Abuse and Mental Health Services Administration","year":"2023"},{"key":"10.1016\/j.ypmed.2023.107777_bb0410","series-title":"Oregon Board disciplines doctor for not treating patients\u2019 pain","author":"Times","year":"1999"},{"issue":"1","key":"10.1016\/j.ypmed.2023.107777_bb0415","first-page":"1","article-title":"Opioid guidelines in the management of chronic non-cancer pain","volume":"9","author":"Trescot","year":"2006","journal-title":"Pain Physician"},{"key":"10.1016\/j.ypmed.2023.107777_bb0420","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1615\/CritRevPhysRehabilMed.v10.i2.40","article-title":"Treatment of chronic pain patients: clinical outcomes, cost-effectiveness, and cost-benefits of multidisciplinary pain centers","volume":"10","author":"Turk","year":"1998","journal-title":"Critical Rev Phys. Rehabil Med"},{"key":"10.1016\/j.ypmed.2023.107777_bb0425","series-title":"The Management of Opioid Therapy for Chronic Pain","author":"VA\/DoD Opioid Therapy for Chronic Pain Working Group","year":"2010"},{"issue":"4","key":"10.1016\/j.ypmed.2023.107777_bb0430","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2023.107777_bb0435","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.ypmed.2023.107777_bb0440","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ypmed.2023.107777_bb0445","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1526-4637.2006.00254.x","article-title":"The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse","volume":"8","author":"Wiedemer","year":"2007","journal-title":"Pain Med (Malden, Mass.)"},{"issue":"9","key":"10.1016\/j.ypmed.2023.107777_bb0450","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/1529-0131(199809)41:9<1603::AID-ART10>3.0.CO;2-U","article-title":"Codeine and oxycodone use in patients with chronic rheumatic disease pain","volume":"41","author":"Ytterberg","year":"1998","journal-title":"Arthritis Rheum."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523003638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743523003638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:22:19Z","timestamp":1758795739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743523003638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":85,"alternative-id":["S0091743523003638"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107777","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The United States opioid crisis: Big pharma alone is not to blame.\u201d","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2023.107777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107777"}}